Innovative Roles Between Medical and Commercial – Where Should the Limit Be?

This webinar aims to explore and provide a nuanced understanding of Innovative Medical Affairs roles within the pharmaceutical industry for critical evaluation by the Medical Affairs community, including new “Hybrid Medical Science Liaison (MSL)” roles ranging from business savvy to more commercially aware MSLs.

Experienced industry representatives will engage in a thoughtful examination of the origins of new structures and roles and their varying potential interpretations. Drawing from real-world examples, they will illustrate the practical implications within their respective companies. The central theme of this discussion revolves around striking a balance between scientific objectivity and commercial awareness, while also addressing the ethical and compliance considerations associated with the role.

The goal of this webinar is to provide a platform for meaningful discourse. By discussing the Hybrid MSL role, our objective is to encourage best practices and start developing a consensus on the associated opportunities and limitations of the role.

This webinar will:

1. Provide participants with a comprehensive understanding of the hybrid MSL role and its diverse interpretations within the pharmaceutical industry.
2. Offer real-world examples and case studies from experienced pharmaceutical professionals, allowing attendees to glean practical insights.
3. Foster a heightened awareness of the ethical and compliance considerations inherent to the hybrid MSL role.
4. Initiate collaboration: Encourage open dialogue and critical thinking within the Medical Affairs community, to work toward a consensus on the evolving scope and potential best practices for the hybrid MSL role.

Moderator:

Lorenzo D’Angelo

Principal / Life Sciences Strategy Consulting

Charles River Associates

Speaker:

Minna Korolainen

Global Medical Lead Neurological Disorders

Orion Corporation

Speaker:

Paulo Antonia Caoile

Patient Journey Partner

Roche

Speaker:

Kaitlyn Edsall Austin

MBA, Vice President, Life Sciences

Charles River Associates